Brain Receptors And Mental Health: New Possibilities For Depression And Anxiety

Depression and anxiety are among the most common mental health challenges worldwide. The World Health Organization (WHO) estimates that globally, 3.8% of people have been diagnosed with major depression and 4% with anxiety disorders. For now, researchers don’t have an exact answer for why these illnesses are so common, but many believe they may be caused by a complex combination of genetic, physiological, and environmental factors. 

With the rise in anxiety and depression cases comes a bigger push to explore the connections between mental health conditions and brain functioning. A better understanding of the underlying mechanisms may help scientists develop more effective treatments that improve the mental health and quality of life of millions of people. 

Here, we’ll explore the relationship between neurophysiology and mental health and how it informs the methods clinicians use to treat mental illness. We’ll also outline new research on the link between brain functioning and mental health and explore how scientists can use these discoveries to develop improved treatment options for brain disorders like anxiety and depression.  

The central nervous system, stress, and emotional regulation

The central nervous system (CNS)—particularly specific regions of the human brain like the amygdala and hypothalamus—plays a critical role in regulating stress and emotions. These areas determine whether external stimuli are threatening or non-threatening and then activate the appropriate response through the autonomic nervous system (ANS). If the stimuli are interpreted as non-threatening, the information is passed on to the parasympathetic branch of the ANS, signaling relaxation. 

However, if the stimuli are interpreted as potentially threatening, the ANS informs the sympathetic branch, signaling the release of stress hormones like cortisol and adrenaline. These hormones prepare the body to "fight or flight" in stressful situations, leading to physiological changes like increased heart rate and blood pressure. 

Dysfunction in the process can cause a chronic state of hyperarousal, producing stress hormones like cortisol and adrenaline regardless of the threat presence. This constant activation of the stress response may disrupt brain function—especially its ability to regulate stress and emotions. Over time, an overactive stress response can cause serious physical and mental health challenges.

The relationship between brain receptors and mental health  

Brain receptors are protein molecules on the surface of brain cells that bind with neurotransmitters like serotonin, dopamine, and norepinephrine to pass chemical signals between neurons. This process, called neurotransmission, and the receptors that facilitate it are important for several mechanisms, including:

• Memory

• Cognitive functioning

• Emotional regulation

• Behavioral regulation

• Social bonding

• Neuronal survival

Imbalances in receptor functioning may result from several factors—one of which is chronic stress—that can significantly contribute to the development of mental health conditions like depression, anxiety, bipolar disorder, schizophrenia, and others. 

Receptor dysfunction in major depression and anxiety disorders 

Anxiety and depression are serious mental health conditions, and understanding their underlying mechanisms is critical for helping clinicians deliver effective diagnoses and treatments. Although studies are ongoing, imbalances or abnormalities in specific neurotransmitter receptors have been strongly implicated in the development and manifestation of these conditions. 

For example, older studies reveal decreased activity or binding of brain serotonin at particular receptors in individuals with depression and anxiety, potentially leading to diminished signal transmission within the brain. Past studies have also implicated norepinephrine receptor imbalances (another neurotransmitter) in the development of mood disorders. Understanding these individual receptor profiles could help clinicians tailor treatments to better address the specific neurochemical imbalances contributing to a person's mood disorder. 

Selective serotonin reuptake inhibitors (SSRIs) for anxiety and depression

Many medications prescribed for depression and anxiety target neurotransmitter receptors, aiming to modulate their activity and restore balance. One of the most common types is selective serotonin reuptake inhibitors (SSRIs). 

SSRIs are antidepressant medications that work by selectively blocking the reabsorption of serotonin, a neurotransmitter affecting sleep, mood, and other functions integral to mental health. Blocking the brain’s serotonin uptake makes more serotonin available to pass between nerve cells, helping reduce depression and anxiety symptoms in many cases.

Selective serotonin reuptake inhibitors (SSRIs) and psychotherapy for brain receptors and mental health

While SSRIs can be highly effective for many people, they aren’t typically used as a sole treatment method. Most mental health professionals who prescribe SSRIs also recommend psychotherapy, particularly cognitive behavioral therapy. 

Multiple meta-analyses suggest clear evidence that combining the two can be highly effective for treating conditions like anxiety and depression. That said, outcomes may vary depending on the specific type of therapy and individual patient factors. Remember to not start, stop, or change any medication without consulting your doctor.

Promising new research: the potential next generation of receptor-specific medications

There are dozens of different types of receptors located on the brain’s nerve cells that may influence mental health, including G-protein-coupled receptors. Serotonin, dopamine, norepinephrine, and epinephrine are all examples of these. Scientists have studied G protein-coupled receptors and how they impact mental health for decades, including a specific “orphan” receptor called GPR158. 

An orphan receptor is a protein for which an activating ligand, or signaling molecule, remains unknown to researchers. Older studies have suggested that GPR158 may play a role in mood regulation—particularly influencing stress and depression-related behaviors—but uncertainty about its ligand created an incomplete picture of exactly how. However, more recent research has identified glycine as GPR158’s ligand, giving scientists new insights into the receptor’s functional role and revealing new information about glycine itself. This understanding opens potential doors for targeted therapies, especially for neuropsychiatric conditions like depression and anxiety.

Innovations in treating mental health conditions

For example, increased knowledge of the complex mechanisms in the brain can help researchers develop medications with fewer side effects or other alternative therapies to medication intervention. Many new approaches have emerged from a need to find alternative options for cases in which individuals don’t respond to initial treatment methods, referred to as treatment-resistant conditions. 

New developments in medication targeting brain receptors

Over the past few years, several new pharmacological treatments for mental health disorders have been approved for public use. For example, there have been two new oral medications developed to treat schizophrenia with co-occurring depression and bipolar disorder. Esketamine was also approved by the FDA in 2019 in the form of a nasal spray for treatment-resistant depression. Muscle injections are also now available for treating schizophrenia and schizoaffective disorder. Additionally, an IV infusion has been approved to treat postpartum depression. 

Noninvasive central nervous system therapies for treatment-resistant depression 

Advancements in functional magnetic resonance imaging (fMRI) have enabled doctors to better “map” specific brain regions associated with psychiatric disorders like major depressive disorder. Identifying these regions and their receptor activity helps specialists deliver more effective, targeted neuromodulation therapies such as transcranial magnetic stimulation (TMS) and deep brain stimulation (DBS). This understanding also contributes to further research that can aid in developing more sophisticated neuromodulation devices in the future. 

Pharmacogenomic treatment approaches for mental health conditions

Pharmacogenomics is an evidence-based approach developed under the umbrella of precision medicine. In this approach, a specialist analyzes an individual’s genes to gather knowledge about their unique physiology. 

Within the mental health field, research suggests that pharmacogenomics may be a valuable tool for helping physicians understand how a patient’s body may react to certain medications. This technology may then allow them to develop the best treatment tailored to each patient’s individual needs.  

Personalized medicine and the future of psychotherapy

Advancement in the study of mental health has given hope to many individuals who struggle with depression and anxiety. In addition to physiological treatments like medication and neuromodulation therapies, researchers are also exploring how the format of psychotherapy can impact mental health outcomes. Studies on therapeutic efficacy reveal new methods that may offer a more specialized and effective approach to treatment. 

For example, the increased popularity of holistic care suggests a shift from a symptom-based approach to a more well-rounded model that focuses on the connection between mental and physical health. With this kind of approach, therapists consider the individual's cognitive, emotional, physical, social, and spiritual well-being when devising a treatment plan.

Culturally competent care is another example of a current trend in successful psychotherapeutic methods. Cultural competency refers to the ability of a therapist to understand and respect the experiences of individuals from diverse backgrounds while addressing their own biases to provide practical, appropriate, and sensitive treatment. It’s a client-centered approach tailored to fit the patient's cultural context and beliefs. 

Technology as a tool for effective care

Technology is also transforming mental health care with mobile apps and telehealth platforms. Options like online therapy can increase the availability of care and eliminate some of the treatment barriers people may face to receiving mental health services. 

For example, some individuals may live in areas with few mental health care providers, while others may not have transportation to get to and from in-person appointments. Online therapy can be a more readily available option in such cases. Virtual mental health care can also be a more comfortable solution for individuals with concerns about mental health stigma, since it allows them to attend appointments from the comfort of home. 

Although it may not be appropriate in every case, such as when immediate in-person care for acute symptoms is needed, abundant research suggests that online therapy can often be as effective as conventional, in-person therapy for many mental health conditions. For example, one meta-analysis reviewed 13 studies involving 1,897 participants who received online therapy during the height of the COVID-19 pandemic. Overall, the participants reported that online psychotherapy significantly reduced their depression, anxiety, and stress levels.